Boros I, Keszler P, Szombath D, Pósch E
Semmelweis Orvostudományi Egyetem, Orálbiológiai Tanszék, Budapest.
Fogorv Sz. 1993 Aug;86(8):265-73.
It has been demonstrated, that the H2-receptor antagonists: cimetidine and ranitidine-administered in doses of the same order of magnitude as reported for the inhibition of rat gastric secretion and development of the experimentally induced gastric and duodenal ulcer-are capable of increasing significantly the parotid secretion evoked by the cholinergic stimulant bethanechol. The salivary carbonic anhydrase activity was also elevated after combined treatment of bethanechol(+)-cimetidine. The similar action of the two H2-antagonists appears to suggest that their effect on salivation is connected probably with the cholinergic activity and it is concluded that the combination of bethanechol with these blockers may improve the esophageal clearance, an action that may be beneficial in the treatment of the gastroesophageal reflux disease.
已经证明,H2受体拮抗剂西咪替丁和雷尼替丁,以与报道的抑制大鼠胃酸分泌及实验性诱发的胃和十二指肠溃疡形成相同数量级的剂量给药时,能够显著增加胆碱能兴奋剂氨甲酰甲胆碱诱发的腮腺分泌。在氨甲酰甲胆碱(+)-西咪替丁联合治疗后,唾液碳酸酐酶活性也升高。两种H2拮抗剂的类似作用似乎表明它们对唾液分泌的影响可能与胆碱能活性有关,并且得出结论,氨甲酰甲胆碱与这些阻滞剂的联合使用可能会改善食管清除率,这一作用可能对胃食管反流病的治疗有益。